January 20, 2022
Boston, MA, January 20, 2022 – Oxeia Biopharmaceuticals, a clinical stage biotech company conducting Phase 2 clinical trials of OXE103 for treating concussion, today announced […]
November 3, 2021
Automated Peripheral Mechanical Stimulation improves patient mobility Non-invasive mechanical device stimulates nerves in patients’ feet Custom-fitted “boots” ensure contact points alignment Device is internationally patented […]
October 21, 2021
Exacis Biotherapeutics Exacis uses proprietary mRNA-based cell engineering to develop off-the-shelf immune cell therapies for cancer treatment from induced pluripotent stem cells (iPSCs) Exacis has […]
September 10, 2021
Exacis Biotherapeutics Pamela Munster, MD, to advise on aspects of solid tumor treatment Caron Jacobson, MD, MMSc, to advise on cell therapy development and clinical […]